| 臺大學術典藏 |
2020-08-12T06:34:10Z |
Pulmonary pleomorphic carcinoma with pembrolizumab monotherapy
|
Chang H.-C.;Hsu C.-L.;Chang Y.-L.;Chong-Jen Yu; Chang H.-C.; Hsu C.-L.; Chang Y.-L.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:34:10Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Liu Y.-N.; CHONG-JEN YU; Shih J.-Y.; Lin Y.-T.;Tsai T.-H.;Wu S.-G.;Liu Y.-N.;Chong-Jen Yu;Shih J.-Y.; Lin Y.-T.; Tsai T.-H.; Wu S.-G. |
| 臺大學術典藏 |
2020-04-08T10:35:55Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Chia-Chi Hsu; Bin-Chi Liao; Wei-Hsun Hsu; Jih-Hsiang Lee; Chia-Chi Lin; Jin-Yuan Shih; James C.-H. Yang; Chong-Jen Yu; Ching-Yao Yang; Wei-Yu Liao; Chao-Chi Ho; Kuan-Yu Chen; Tzu-Hsiu Tsai; Chia-Lin Hsu; Kang-Yi Su; Yih-Leong Chang; Chen-Tu Wu; Chong-Jen Yu;James C.-H. Yang;Jin-Yuan Shih;Chia-Chi Lin;Jih-Hsiang Lee;Wei-Hsun Hsu;Bin-Chi Liao;Chia-Chi Hsu;Chen-Tu Wu;Yih-Leong Chang;Kang-Yi Su;Chia-Lin Hsu;Tzu-Hsiu Tsai;Kuan-Yu Chen;Chao-Chi Ho;Wei-Yu Liao;Ching-Yao Yang |
| 臺大學術典藏 |
2020 |
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer
|
Yang W.-C.;Hsu F.-M.;Chen Y.-H.;Shih J.-Y.;Chong-Jen Yu;Lin Z.-Z.;Lu S.-H.;Yang J.C.-H.;Cheng A.-L.;Kuo S.-H.; Yang W.-C.; Hsu F.-M.; Chen Y.-H.; Shih J.-Y.; CHONG-JEN YU; Lin Z.-Z.; Lu S.-H.; Yang J.C.-H.; Cheng A.-L.; Kuo S.-H. |
| 臺大學術典藏 |
2020 |
Clinical features and treatment outcomes of Mycobacterium chimaera lung disease and antimicrobial susceptibility of the mycobacterial isolates
|
Hsueh P.-R.; Chien J.-Y.; Chen L.-C.;Huang H.-N.;Chong-Jen Yu;Chien J.-Y.;Hsueh P.-R.; Chen L.-C.; Huang H.-N.; CHONG-JEN YU |
| 臺大學術典藏 |
2020 |
Impact of different subspecies on disease progression in initially untreated patients with Mycobacterium avium complex lung disease
|
CHONG-JEN YU; Su W.-J.; Chan Y.-J.; Wang J.-Y.; Chien J.-Y.; Feng J.-Y.; Shu C.-C.; Pan S.-W.; Pan S.-W.;Shu C.-C.;Feng J.-Y.;Chien J.-Y.;Wang J.-Y.;Chan Y.-J.;Chong-Jen Yu;Su W.-J. |
| 臺大學術典藏 |
2020 |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020 |
The impact on incident tuberculosis by kidney function impairment status: Analysis of severity relationship
|
CHONG-JEN YU; Wang J.-Y.; Cheng S.-L.; Shu C.-C.; Wei Y.-F.; Yeh Y.-C.; Lin H.-H.; Chen C.-Y.; Wang P.-H.; Shu C.-C.;Wei Y.-F.;Yeh Y.-C.;Lin H.-H.;Chen C.-Y.;Wang P.-H.;Cheng S.-L.;Wang J.-Y.;Chong-Jen Yu |
| 臺大學術典藏 |
2020 |
Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
|
Shaw A.T.; Passos V.Q.; Chen Z.; Viraswami-Appanna K.; Spigel D.R.; Scagliotti G.V.; Mok T.; Su W.-C.; Nishio M.; Felip E.; Orlov S.; Park K.; CHONG-JEN YU; Tsai C.-M.; Cobo M.; McKeage M.; Nishio M.;Felip E.;Orlov S.;Park K.;Chong-Jen Yu;Tsai C.-M.;Cobo M.;Mckeage M.;Su W.-C.;Mok T.;Scagliotti G.V.;Spigel D.R.;Viraswami-Appanna K.;Chen Z.;Passos V.Q.;Shaw A.T. |
| 臺大學術典藏 |
2019-11-08T03:21:46Z |
EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
|
Chang, Chia-Ching; CHONG-JEN YU; PAN-CHYR YANG; CHAO-CHI HO; CHAO-CHI HO;PAN-CHYR YANG;CHONG-JEN YU;Chang, Chia-Ching;Lin, Shr-Uen;HUEI-WEN CHEN;Chen, Hsuan-Yu;SUNG-LIANG YU;Lin, Chih-An; Lin, Chih-An; SUNG-LIANG YU; Chen, Hsuan-Yu; HUEI-WEN CHEN; Lin, Shr-Uen |
| 臺大學術典藏 |
2019-10-23T13:07:21Z |
Prognostic value of the mitogen response in the interferon-γ release assay in patients with culture-confirmed tuberculosis
|
CHONG-JEN YU;JANN-YUAN WANG;CHUN-TA HUANG;MENG-RUI LEE;SHENG-YUAN RUAN;Tsai, Yi Ju; SHENG-YUAN RUAN; Tsai, Yi Ju; MENG-RUI LEE; CHUN-TA HUANG; JANN-YUAN WANG; CHONG-JEN YU |
| 臺大學術典藏 |
2019-10-14T01:40:27Z |
NLRP3 inflammasome is attenuated in patients with Mycobacterium avium complex lung disease and correlated with decreased interleukin-1β response and host susceptibility
|
CHONG-JEN YU;Wu, Lawrence Shih Hsin;BOR-LUEN CHIANG;HSIN-CHIH LAI;BO-SHIUN YAN;JANN-YUAN WANG;CHIN-CHUNG SHU;Wu, Ming Fang; Wu, Ming Fang; CHIN-CHUNG SHU; JANN-YUAN WANG; BO-SHIUN YAN; HSIN-CHIH LAI; BOR-LUEN CHIANG; Wu, Lawrence Shih Hsin; CHONG-JEN YU |
| 臺大學術典藏 |
2019-09-23T02:53:08Z |
Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
|
Liu, Hsiang-Wen;Chen, Yunn-Jy;Lai, Yi-Chun;Huang, Ching-Yi;Huang, Ya-Ling;Lin, Ming-Tzer;Han, Sung-Ying;Chi-Ling Chen;Chong-Jen Yu;Pei-Lin Lee; Liu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN; Chong-Jen Yu; PEI-LIN LEE |
| 臺大學術典藏 |
2019-09-23T02:45:08Z |
Correction: Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
|
Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN; Chong-Jen Yu; PEI-LIN LEE; Liu, Hsiang-Wen; Liu, Hsiang-Wen;Chen, Yunn-Jy;Lai, Yi-Chun;Huang, Ching-Yi;Huang, Ya-Ling;Lin, Ming-Tzer;Han, Sung-Ying;Chi-Ling Chen;Chong-Jen Yu;Pei-Lin Lee |
| 臺大學術典藏 |
2019-09-19T01:16:29Z |
Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
|
Liu, Hsiang-Wen;Chen, Yunn-Jy;Lai, Yi-Chun;Huang, Ching-Yi;Huang, Ya-Ling;Lin, Ming-Tzer;Han, Sung-Ying;Chi-Ling Chen;Chong-Jen Yu;Lee, Pei-Lin; Liu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN; Chong-Jen Yu; Lee, Pei-Lin |
| 臺大學術典藏 |
2019-09-19T01:02:15Z |
Correction: Combining MAD and CPAP as an effective strategy for treating patients with severe sleep apnea intolerant to high-pressure PAP and unresponsive to MAD
|
Liu, Hsiang-Wen;Chen, Yunn-Jy;Lai, Yi-Chun;Huang, Ching-Yi;Huang, Ya-Ling;Lin, Ming-Tzer;Han, Sung-Ying;Chi-Ling Chen;Chong-Jen Yu;Lee, Pei-Lin; Liu, Hsiang-Wen; Chen, Yunn-Jy; Lai, Yi-Chun; Huang, Ching-Yi; Huang, Ya-Ling; Lin, Ming-Tzer; Han, Sung-Ying; CHI-LING CHEN; Chong-Jen Yu; Lee, Pei-Lin |
| 臺大學術典藏 |
2019-09-16T05:44:04Z |
Author reply to Letter to Editor “Weaning outcome of solid cancer patients requiring mechanical ventilation in the ICU: Other factors to explore”
|
PEI-LIN LEE; Chong-Jen Yu;Pei-Lin Lee;Emily Han-Chung Hsiue;Yung-Hsuan Chen; Emily Han-Chung Hsiue; Yung-Hsuan Chen; Chong-Jen Yu |
| 臺大學術典藏 |
2019-09-09T00:55:35Z |
Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors
|
Lim, Chor Kuan;Chang, Lih Chyun;Chen, Kuan Yu;CHONG-JEN YU;JIN-YUAN SHIH;LIH-YU CHANG; LIH-YU CHANG; JIN-YUAN SHIH; CHONG-JEN YU; Chen, Kuan Yu; Chang, Lih Chyun; Lim, Chor Kuan |
| 臺大學術典藏 |
2019-09-09T00:55:35Z |
Effectiveness of Treatments for Advanced Non–Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor Mutations
|
Wu, Jenn Yu; JIN-YUAN SHIH; JIN-YUAN SHIH;Wu, Jenn Yu;CHONG-JEN YU; CHONG-JEN YU |
| 臺大學術典藏 |
2019-07-17T06:58:58Z |
Weaning outcome of solid cancer patients requiring mechanical ventilation in the intensive care unit
|
CHONG-JEN YU;James Chih-Hsin Yang;Huey-Dong Wu;Dai-Lung Chiang;Pei-Yu Lin;Hsing-Wu Chen;Po-Chun Yang;Keng-Man Cheng;Chiao-Feng Cheng;Ting-Hui Wu;Yung-Hsuan Chen;PEI-LIN LEE;Emily Han-Chung Hsiue; Emily Han-Chung Hsiue; PEI-LIN LEE; Yung-Hsuan Chen; Ting-Hui Wu; Chiao-Feng Cheng; Keng-Man Cheng; Po-Chun Yang; Hsing-Wu Chen; Pei-Yu Lin; Dai-Lung Chiang; Huey-Dong Wu; James Chih-Hsin Yang; CHONG-JEN YU |
| 臺大學術典藏 |
2019-03-04T08:13:58Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin, Shu Yung;Yang, Ching Yao;Bin-Chi Liao;Chao-Chi Ho;Wei-Yu Liao;Chen, Kuan-Yu;Tsai, Tzu Hsiu;Chia-Lin Hsu;Hsu, Wei Hsun;Kang-Yi Su;Yih-Leong Chang;Lee, Jih Hsiang;Lin, Chia Chi;Jin-Yuan Shih;Yang, James Chih Hsin;Chong-Jen Yu; Lin, Shu Yung; Yang, Ching Yao; BIN-CHI LIAO; CHAO-CHI HO; WEI-YU LIAO; Chen, Kuan-Yu; Tsai, Tzu Hsiu; CHIA-LIN HSU; Hsu, Wei Hsun; KANG-YI SU; YIH-LEONG CHANG; Lee, Jih Hsiang; Lin, Chia Chi; JIN-YUAN SHIH; Yang, James Chih Hsin; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T08:12:38Z |
Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go?
|
Chen, Kuan-Yu;Tsai, Mao Song;Wei, Yu Feng;Lim, Chor Kuan;CHONG-JEN YU;JIN-YUAN SHIH; Lim, Chor Kuan; Wei, Yu Feng; Tsai, Mao Song; Chen, Kuan-Yu; JIN-YUAN SHIH; Chong-Jen Yu |
| 臺大學術典藏 |
2019-03-04T08:04:19Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
CHONG-JEN YU; CHAO-CHI HO; WEI-YU LIAO; Lee, Jih Hsing; Tsai, Tzu Hsiu; KANG-YI SU; MIN-SHU HSIEH; YIH-LEONG CHANG; Bai, Ya Ying; Huang, Derek De Rui; Thress, Kenneth S.; CHIH-HSIN YANG; JIN-YUAN SHIH; Lin, Chia Chi; Thress, Kenneth S.;Huang, Derek De Rui;Bai, Ya Ying;Lee, Jih Hsing;Lin, Chia Chi;CHIH-HSIN YANG;YIH-LEONG CHANG;MIN-SHU HSIEH;KANG-YI SU;Tsai, Tzu Hsiu;WEI-YU LIAO;CHAO-CHI HO;CHONG-JEN YU;JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T07:51:37Z |
Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
|
Yang, James Chih Hsin;Liu, Yi-Nan;Wu, Shang-Gin;JIN-YUAN SHIH;CHONG-JEN YU; Wu, Shang-Gin; Liu, Yi-Nan; Chong-Jen Yu; Yang, James Chih Hsin; JIN-YUAN SHIH |
| 臺大學術典藏 |
2019-03-04T07:47:57Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Chen, Kuan-Yu;Tsai, Tzu Hsiu;CHONG-JEN YU;JIN-YUAN SHIH;CHAO-CHI HO;WEI-YU LIAO; WEI-YU LIAO; CHAO-CHI HO; Tsai, Tzu Hsiu; Chen, Kuan-Yu; JIN-YUAN SHIH; Chong-Jen Yu |
